20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Exploring the Role of Azetidine Derivatives in Modern Pharmaceuticals

At NINGBO INNO PHARMCHEM CO.,LTD., we are constantly exploring innovative chemical compounds that drive progress in the pharmaceutical industry. Among these, azetidine derivatives have emerged as particularly significant. These four-membered heterocyclic rings offer a unique structural scaffold that can impart desirable properties to drug molecules, influencing their efficacy, bioavailability, and metabolic stability.

One such key compound is 1-Benzhydrylazetidin-3-amine (CAS No. 40432-52-8). This molecule serves as a vital pharmaceutical intermediate, enabling the synthesis of complex active pharmaceutical ingredients (APIs). Its structure, featuring a benzhydryl group attached to an azetidine ring with an amino substituent, makes it a versatile building block for medicinal chemists. The ability to buy 1-Benzhydrylazetidin-3-amine is crucial for researchers focused on developing new therapeutic agents.

The significance of 1-Benzhydrylazetidin-3-amine lies not only in its structural novelty but also in its potential applications. Research has indicated that azetidine derivatives can exhibit dopamine antagonistic activity, suggesting their utility in developing treatments for neurological disorders. For those seeking high-purity pharmaceutical intermediates, sourcing this compound is a strategic step in advancing drug discovery programs. The availability of such specialized chemicals directly impacts the pace and success of research and development efforts.

We understand the critical need for reliable chemical suppliers in the R&D process. NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing high-quality chemical building blocks that meet the stringent demands of pharmaceutical research. Whether you are investigating new synthetic pathways or exploring novel drug targets, having access to compounds like 1-Benzhydrylazetidin-3-amine is paramount. Our focus on quality ensures that you receive materials that contribute positively to your research outcomes, allowing you to move forward with confidence in your pursuit of innovative medicines.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Safety and Handling of Dichlorophen (CAS 97-23-4): A Guide for Users

Next: The Strategic Importance of 1-Benzhydrylazetidin-3-amine in Pharmaceutical R&D

All Rights Reserved